$CLYD

BEACON TOPCO, INC.

0
1
1

No SEC Form 4 filings for $CLYD in the last 30 days.

See all $CLYD insider activity →
Med

CLYD (CLYD): Completion of Acquisition or Disposition of Assets

CLYD (CLYD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 CLYWEDOG THERAPEUTICS, INC. Condensed Consolidated Financial Statements As of June 30, 2026 and December 31, 2025 and for the Three and Six Months Ended June 30, 2026 and 2025 TABLE OF CONTENTS Condensed Consolidated Financial Statements Condensed Consolidated Balanc

Ghana: GSE Records Positive 0.34 Percent Average Share Price Gain...As Trading Value Rises 15.37 Percent

Ghana Stock Exchange (GSE) saw a 0.34% average share price gain for the week of November 9-13, 2026, with total trading value rising 15.37% to GH¢80.31 million. Top performers included Consumer Products Company (CPC) (+40.82%), DIGICUT (+11.43%), and DASPHARMA (+5.77%). Market capitalization fell slightly by 0.34% to GH¢262.39 billion, while trading volume dropped 59.32% to 7.80 million shares.

BEACON TOPCO, INC. (CLYD): Entry into a Material Definitive Agreement

BEACON TOPCO, INC. (CLYD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Amendment to the Merger Agreement As previously disclosed, on September 29, 2025, Beacon Topco, Inc., a Delaware corporation (“ Topco ”), entered into an Agreement and Plan of Merger by and among Topco, Barinthus Biotherapeuti

CLYD sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CLYD (BEACON TOPCO, INC.). Coverage has skewed bearish: 0 bullish, 1 neutral, and 1 bearish.

Recent CLYD coverage spans market movers, corporate actions and earnings.

What's driving CLYD

  • Asset disposition completion can change CLYD’s cash runway, liabilities, and future operating plan, driving a re-rating of liquidity risk.

    SEC EDGAR 8-K · Nov 20, 2026

  • Negative sentiment for CLYD tied to the reported weekly underperformance.

    allafrica.com · Nov 17, 2026

  • The amendment clarifies the timeline for the Topco‑Beacon‑Clywedog merger, reducing uncertainty.

    SEC EDGAR 8-K · Nov 5, 2026

  • The data suggest a potentially disease-modifying therapy, likely driving short‑term upside and increased analyst coverage.

    SEC EDGAR 8-K · Sep 24, 2026

  • Profit resilience appears driven by recurring services and fee income, while revenue weakness is attributed to one-off 2025 hardware and delayed orders.

    newsghana.com.gh · Jul 20, 2026

AlphAI scores every news story that mentions CLYD with an AI model for sentiment and relevance, and aggregates insider trades from BEACON TOPCO, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CLYD

Score
$CLYDMedM&A· target

CLYD (CLYD): Completion of Acquisition or Disposition of Assets

CLYD (CLYD) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 CLYWEDOG THERAPEUTICS, INC. Condensed Consolidated Financial Statements As of June 30, 2026 and December 31, 2025 and for the Three and Six Months Ended June 30, 2026 and 2025 TABLE OF CONTENTS Condensed Consolidated Financial Statements Condensed Consolidated Balanc

Ghana: GSE Records Positive 0.34 Percent Average Share Price Gain...As Trading Value Rises 15.37 Percent

Ghana Stock Exchange (GSE) saw a 0.34% average share price gain for the week of November 9-13, 2026, with total trading value rising 15.37% to GH¢80.31 million. Top performers included Consumer Products Company (CPC) (+40.82%), DIGICUT (+11.43%), and DASPHARMA (+5.77%). Market capitalization fell slightly by 0.34% to GH¢262.39 billion, while trading volume dropped 59.32% to 7.80 million shares.

$CLYDMedM&A· acquirer · definitive

BEACON TOPCO, INC. (CLYD): Entry into a Material Definitive Agreement

BEACON TOPCO, INC. (CLYD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Amendment to the Merger Agreement As previously disclosed, on September 29, 2025, Beacon Topco, Inc., a Delaware corporation (“ Topco ”), entered into an Agreement and Plan of Merger by and among Topco, Barinthus Biotherapeuti

$CLYDHighClinical / regulatory· topline data

BEACON TOPCO, INC. (CLYD): Entry into a Material Definitive Agreement

BEACON TOPCO, INC. (CLYD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Exhibit 99.1 FOR IMMEDIATE RELEASE Clywedog Therapeutics Announces Final Results from a Phase 1b Study of Balomenib in Type 2 Diabetes Patients, Showing Glycemic Improvement Sustained for Three Months After a Three-Week Course of Treatment o Placebo-adjusted mean HbA1c reduction

Clydestone Profit Holds Despite Revenue Plunge

Clydestone Ghana Plc reported unaudited Q1 2026 consolidated net profit of GH¢239,522 despite revenue dropping 93% to GH¢1,432,125 from GH¢19,775,067 a year earlier, which the company attributed to a one-off hardware delivery in 2025. Gross margin rose to 92.8%. Management cited two banking hardware orders confirmed in Q2 for delivery in Q3 and progress on SusuCard pending Bank of Ghana clearance.

Clydestone Extends Profit Run As Cash Falls

Clydestone Ghana Plc (GSE: CLYD) reported a second consecutive profitable quarter through June. For the six months ended June 30, net profit after tax was GH¢273,326 versus GH¢1,093,650 a year earlier, with revenue at GH¢3,297,523 down from GH¢20,868,381. Cash fell to GH¢379,127 and current liabilities rose to GH¢7,471,085. Management cited hardware comparatives and said H1 2026 revenue came from recurring services; two hardware orders are expected to be recognized in Q3.